Development and Strategic Consulting Associates

Development and Strategic Consulting Associates (DSCA) is a specialized boutique consultancy providing high-level strategic and regulatory guidance to the biopharmaceutical industry. The firm is led by Dr. Robert J. Meyer, a former high-ranking FDA official with extensive experience in drug evaluation and regulatory policy. DSCA assists clients in designing efficient clinical development programs, preparing for critical regulatory milestones, and navigating complex approval processes with the FDA and other global agencies. Their expertise is frequently sought for high-stakes interactions, including Advisory Committee meetings and New Drug Application (NDA) strategies. By leveraging deep regulatory insights, the firm helps companies align their clinical objectives with evolving regulatory expectations to optimize the path to market.